RYAH Medtech Inc, the company behind the first dose-measuring vaporizer, is making a strong play for the Canadian Security Exchange by moving forward with a reverse takeover of Prime Blockchain.
The privately held companies signed a binding letter of intent under which Prime Blockchain will acquire any outstanding securities of RYAH’s parent company.
The Quebec company will be required to change its name and replace its directors with nominees from RYAH.
Prime Blockchain is a company in good standing with the CSE, RYAH CEO Greg Wagner told Proactive, and one that the exchange has already done due dilligence on. That makes it easier for the combined company to go public.
“This new letter of intent was executed for the purpose of accelerating our listing plans on the CSE and further reflects our commitment to provide liquidity, transparency and new opportunities to strategic partners, future investors and current investors alike,” Wagner said.
RYAH Medtech is a New York-based company that brings big data to dry herb medicine. Its signature vaporizer can precisely track dose and temperature and pairs with an app that uses artificial intelligence to help patients identify what treatments work best for them.
Contact Andrew Kessel at firstname.lastname@example.org
Follow him on Twitter @andrew_kessel